Oxford BioMedica provided capital expenditure guidance for the year 2015/2016. For the year, the company expected capital expenditure to be in the range of £20 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
328 GBX | +1.23% | +2.16% | +48.82% |
05-09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
05-09 | Molten Ventures wins UK MoD supply contract | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.82% | 414M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.89% | 22.67B | |
-9.74% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford BioMedica Provides Capital Expenditure Guidance for the Year 2015/2016